INFORMATION FOR AUTHORS

EDITORS-IN-CHIEF
Edward B. Diethrich, MD, and Thomas J. Fogarty, MD
EDITORIAL OFFICE
Rebecca Bowman, Managing Editor
Journal of Endovascular Therapy
1928 East Highland Avenue, #F104-605
Phoenix, AZ 85016 USA
Telephone: 1-602-650-1331; Fax: 1-602-650-1345
E-mail: editor@jevt.org 

SCOPE AND CONTENT
The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery), an official publication of the INTERNATIONAL SOCIETY OF ENDOVASCULAR SPECIALISTS (ISES), was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. The Journal seeks to support vascular specialists of all disciplines, improve patient care, and promote research and development by publishing peer-reviewed clinical and experimental studies and other materials related to the field of peripheral endovascular interventions.
    The Journal will entertain original contributions, reviews, case reports, and technical notes on clinical or laboratory investigations of peripheral endoluminal therapies and research related to new endovascular technologies and techniques. At the discretion of the Editors, the Journal publishes editorials and letters and will designate especially timely or evolutionary articles as Rapid Communications or Works in Progress. Back to Top

EDITORIAL POLICIES
Originality
Materials submitted to the Journal must be original; they cannot have been previously published (other than as abstracts) nor can they be under simultaneous consideration by any other publication. If the work has been presented at a meeting or has been published as an abstract, a statement to this effect must appear on the title page, identifying the meeting, location, and date or details of the abstract publication. In general, manuscripts will not be considered if the work has been published in full-length conference proceedings or as a book chapter. Back to Top
Authorship Responsibility
All authors must have made a direct and substantial contribution to this work sufficient to take public responsibility for a meaningful share of its contents. At the request of the editors or their assignees, the authors may be required to produce for examination the data on which this manuscript is based. Statements affirming originality and authorship responsibility must be included in the submission letter. Back to Top
Conflict of Interest Disclosure
Authors are obliged to disclose in the submission letter and on the title page of the manuscript any financial arrangement or other relationship that could be construed as a conflict of interest for any product mentioned in the manuscript. These arrangements include but are not limited to employment, direct payments, stock holdings, retainers, paid or unpaid consultancies, patents or patent licensing arrangements, research funding, speakers’ bureau, or honoraria with any individual, company, or organization having a vested interest in the subject matter or products mentioned in the manuscript. Declared relationships are not divulged to reviewers, but appropriately formatted statements will appear as a footnote on the first page on every published article, including editorials, commentaries, and correspondence.
    If the Editors believe or are notified that an author may have failed to make an appropriate disclosure, the author will be contacted. Depending upon the response, the Editors will decide if an erratum correcting the oversight should be published or if more serious action is warranted in the case of deception. In that event, the Editors may publish a notice that the author did not comply with the Journal’s requirement to disclose a conflict of interest, calling into question the reliability of the article. Back to Top
Copyright Transfer
Authors of articles, commentaries, editorials, and correspondence must agree in writing to transfer, assign, and convey all copyright ownership of their accepted materials to the INTERNATIONAL SOCIETY OF ENDOVASCULAR SPECIALISTS. Thus, manuscripts accepted for publication become the permanent property of the SOCIETY and may not be published elsewhere by the authors without written permission from the Journal. Manuscripts written by employees of the federal government during the course of their official duties may not be copyrightable. If an author falls under this designation, it should be appropriately noted in the submission letter. Electronic copies of the copyright documents are kept indefinitely. An individual may make a single photocopy of a published article for his or her personal use, but multiple copies cannot be made without the written permission of the Journal or from the Copyright Clearance Center. Back to Top
Attestation
All authors of accepted articles, commentaries, editorials, and correspondence are required to sign the Mandatory Conflict of Interest Disclosure, Copyright Transfer, and Author Responsibility Affirmations form, which is sent with the acceptance message and contains the following statements:
ORIGINALITY: I warrant that this article is original in form and substance, contains no unlawful or libelous statements, and does not infringe on the rights of others. Furthermore, none of its material has been published previously in print, digital, or analogue media (except abstracts) or is under consideration for publication elsewhere. I have approved the final version of the manuscript, and I believe the facts it contains to be true.
AUTHORSHIP RESPONSIBILITY: I have made a direct and substantial contribution to this work sufficient to take public responsibility for a meaningful share of its contents. If the editors or their assignees so request, I agree to produce for examination the data on which this manuscript is based.
CONFLICT OF INTEREST: By checking “No” below, I attest that I have no association (including but not limited to employment, direct payments, stock holdings, retainers, paid or unpaid consultancies, patents or patent licensing arrangements, research funding, speakers’ bureau, or honoraria) with any individual, company, or organization with a vested interest in the subject matter/products mentioned in the manuscript. A check in the “Yes” box warrants that any conflict has been disclosed in the submission letter and manuscript or in a document returned with this form.
COPYRIGHT TRANSFER: I transfer in perpetuity and throughout the world the copyright of this manuscript to the INTERNATIONAL SOCIETY OF ENDOVASCULAR SPECIALISTS. This transfer includes the right to reproduce all or part of the article in other media (including but not limited to digital and/or electronic files) for incorporation in computerized retrieval systems or other publication formats.
This signed document must be returned to the Editorial Office before the material can be scheduled for publication. Back to Top
Ethical and Animal Experimentation Approval
Studies involving human subjects or animal models must have the approval of the Institutional Review Board (IRB) or other agency responsible for human and/or animal research at the authors’ institution(s). Human subjects must have given written informed consent to the study in a document approved by the IRB or similar governing body. Experimental animals must have been cared for according to the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Washington, DC: National Academy Press; 1996) or similar national guidelines. Statements certifying compliance with these requirements must appear in the Methods section of the manuscript. Back to Top
Peer Review
All manuscripts are reviewed initially by the Chief Editors and Managing Editor. A submission is rejected outright if the majority opinion finds that (1) the material does not have sufficient merit to warrant further review or (2) the subject matter is outside the scope of the Journal. The submission may also be returned for inadequate presentation or failure to comply with the Journal’s submission guidelines published in the Information for Authors.
     Manuscripts passing the initial evaluation will undergo blinded and anonymous review by two or more experts in the field. The identities of the authors are removed from the review version of the manuscript, and the names of the reviewers are never revealed to the authors. Reviewers are asked to give a confidential opinion on the importance, originality, and scientific merit of the manuscript and suggest changes that will improve the article. A formal statistical review may be obtained at the discretion of the Editors.
     The Editorial Office will relay via e-mail the final decision on the disposition of the manuscript to the corresponding author along with the reasons for the decision and, when appropriate, the comments from the reviewers. If revisions are requested, the authors are expected to revise the manuscript appropriately and promptly, clearly indicating the changes that have been made and/or explaining their differences of opinion with the reviewers’ comments. The Editorial Office will inform the reviewers of the final decision, accompanied by the comments of both reviewers. Back to Top
Publication and Reprints
Accepted manuscripts will be scheduled for publication generally in the order in which they are received after no further author revisions are required and the Mandatory Conflict of Interest Disclosure, Copyright Transfer, and Author Responsibility Affirmations form has been received from all authors.
    The Journal reserves the right to edit accepted manuscripts to comply with the Journal’s format, to remove redundancies, to correct grammatical faults, and to improve readability without altering the meaning. Several weeks before the scheduled publication of an article, the edited version of the manuscript will be sent via e-mail to the corresponding author for approval. Within 3 weeks after the author returns the approved/corrected edited version, a PDF file of the page proof will be sent by e-mail for approval. At this stage, only correction of typographical errors or mistakes in the presentation of data can be made, provided the material is returned to the Editorial Office within 72 hours.
    Reprints will be furnished to authors when ordered in advance of publication and prepaid. An order form with price information will be sent to the author with the page proof. A complimentary PDF of the final article will be sent to the corresponding author after publication. Back to Top
 
MANUSCRIPT PREPARATION
All materials considered for publication must be submitted in English to the Editorial Office accompanied by a submission letter attesting that (1) there has been no duplicate publication or submission of any part of the work; (2) all authors have read and approved the manuscript; and (3) any potential conflict of interest (see Editorial Policies) has been declared. If a potential conflict exists, its nature should be stated in the letter and on the title page of the manuscript for each author involved. A conflict of interest statement will appear as a footnote on the title page of all articles, commentaries, and editorials.
    Authors are encouraged to consult the American Medical Associations’ Manual of Style (9th ed., Baltimore, MD: Williams & Wilkins, 1998) or "Uniform Requirements for Manuscripts Submitted to Medical Journals" (International Committee of Medical Journal Editors. JAMA. 1997;277:927-934) for guidance in text preparation and reference citation. Back to Top
 

ELECTRONIC TEXT ENTRY INSTRUCTIONS
The Journal requires all materials to be in a digital format. The Editorial Office can access text and image files produced by most common software applications for the PC and Macintosh (MAC) platforms. However, to ensure that formatting and symbols are not lost in any file conversion, follow these guidelines for file preparation.  Back to Top
  • Use a nonproportionally spaced font of at least 12 pitch; do not embed the font.
  • Set line spacing to double; full justification may be used.
  • Use tabs at 0.5-inch increments for paragraph and text indentation; do not use hanging indents.
  • Set all margins to 1 inch (25 mm) and headers/footers to 0.5 inches (12 mm) from the edge.
  • Turn off automatic hyphenation; use 2 hyphens for short (en) dashes and 3 hyphens for long (em) dashes.
  • Number pages consecutively, beginning with the title page. Place only the page number and a brief title (no author name) (e.g., Stenting in the SFA - page 2) in the header at the right margin; no lines or other formatting should appear to demarcate text or headers. Do not place any text or formatting in the footers. Back to Top
  • Type section heads in bold capital letters at the left margin (do not center) followed by a hard return (enter key); subheads appear in bold initial capitals at the left margin followed by a hard return (enter). Third-level heads are in italicized bold type (first word capitalized) and indented to run in with the text.
  • Type text within paragraphs using the word wrap (soft return) feature. Do not enter a hard return at the end of each line.
  • Do not embed fonts, links, footnotes in a hidden field, field codes, bookmarks, comments, hypertext links, or passwords in the text. See Charts, Graphs, and Equations and Figures and Legends for specific instructions for processing these items. Do NOT use endnotes or other bibliographic style function for reference lists.
  • Use the formatting function for bold, italic, and sub/superscripts. Symbols, foreign letters, and mathematical formulas may be inserted in the text (see Charts, Graphs, and Equations), but they should be verified against the printout before submission. Back to Top
Arranging the Components of the Manuscript
Begin each segment on a new page: title page, abstract and key words, text, acknowledgments, references, tables, legends, and figures. Because the manuscripts will undergo blinded review, no author or institution name should appear in the text or brief title. Back to Top
Title Page
  • List full names, highest academic degrees, and affiliations for all authors.
  • Provide a brief title (<40 characters).
  • Acknowledge all sources of financial support (grants, fellowships, equipment, or remuneration of any kind) or competitive interests for each author (employment, stock holdings, retainers, paid or unpaid consultancies, patents or patent licensing arrangements, speakers' bureau, or honoraria) that may pertain to the topic/materials in the manuscript.
  • Give the name, address, telephone/fax numbers, and e-mail address of a correspondent. NOTE: all correspondence from the Editorial Office is sent via e-mail; no fax or mail delivery is used. Back to Top
Abstract
  • Give a substantive summary of an original article in 250 words, separating the abstract according to Purpose, Methods, Results, and Conclusion; abstracts for reviews may be unstructured. For case reports, the abstract should be no longer than 150 words and divided into Purpose, Case Report, and Conclusion. Technical notes may have a 150-word abstract divided into Purpose, Technique, and Conclusions.
  • List a maximum of 15 key words. Back to Top
Text
  • Organize your text into sections entitled Introduction, Methods, Results, and Discussion (case reports and technical notes require only Introduction, Case Report or Technique, and Discussion).
  • Avoid naming your institution in the work or otherwise identifying the authors.
  • Use Sl measurements; generic drug names should be used.
  • Define abbreviations and acronyms when they first appear in the text.
  • Identify tables and figures using Arabic numerals in parentheses.
  • Place acknowledgments at the end of the text on a separate page. Back to Top
References
  • Follow the guidelines in the American Medical Associations’ Manual of Style (9th ed., Baltimore, MD: Williams & Wilkins, 1998) or "Uniform Requirements for Manuscripts Submitted to Medical Journals" (International Committee of Medical Journal Editors. JAMA. 1997;277:927-934).
  • Do NOT use endnotes or other bibliographic style function for reference lists.
  • Limit to 15 the number of references for a case report or technical note. Letters may have no more than 10 references.
  • Number references in the order they appear in the text. Identify references in the text, tables, and legends as superscript Arabic numerals.
  • List the first 3 authors (last name and initials separated by a comma); use "et al." for 4 or more authors. Back to Top
  • Abbreviate journal titles according to the style of Index Medicus; formats for the common types of journal citations are:
  • Journal article: authors' names and initials, article title, journal name, year, volume, and inclusive page numbers.
    Example: Görich J, Rilinger N, Söldner J, et al. Endovascular repair of aortic aneurysms: treatment of complications. J Endovasc Surg. 1996;6:136-146.
  • Abstracts (no more than 2 years old): authors' names and initials, title followed by [abstract], journal name, year, volume, and inclusive page numbers.
    Example: Reid DB, Diethrich EB. Intravascular ultrasound imaging in carotid artery stenting: results of a prospective study [abstract]. Cardiovasc Surg. 1996;4:661.  Back to Top
  • Cite entire books by giving the author/editor(s), title, edition, city/state of publication, publisher, and year.
    Example: Ahn SS, Moore WS, eds. Endovascular Surgery, 2nd ed. Philadelphia, PA: WB Saunders Co.; 1991.
  • Cite chapters in books giving the author(s), chapter title, editor(s), book title, city/state of publication, publisher, year, and inclusive page numbers.
    Example: Towne JB. Postintervention surveillance. In: White RA, Fogarty TJ, eds. Peripheral Endovascular Interventions. St. Louis, MO: Mosby–Year Book, Inc.; 1996:109-115. Back to Top
Tables
  • Use tables to supplement the text, not duplicate it.
  • Number each table sequentially using Arabic numerals.
  • Give a brief title for each table.
  • Do not insert tables in the text; each should be presented on a separate page with any abbreviations listed alphabetically and defined in a footnote.
  • Format tables for clarity using the table formatting function. Elaborate formatting (shading, color) is discouraged. Back to Top
Charts, Graphs, and Equations
  • Equations referred to in the text should be placed on their own line and numbered serially on the right-hand side of the page, e.g.,  

    Short expressions without a number should  be inline with the text. Complex equations should be prepared with appropriate software and inserted as noted above.

  • Insert and number any charts, graphs, or mathematical models created from spreadsheet or drawing programs at the end of the manuscript with the figures (do not activate the link function [Paste special] to the original program). Remember when formatting charts and graphs that printing color figures is an additional cost to the author. Unless color is essential to a graphic and worth the extra expense, do not design the chart or graph using color. Back to Top
Figures and Legends
  • All figures must be supplied in digital format as specified below; NO PHOTOGRAPHIC PRINTS WILL BE ACCEPTED. Create digital images with high-quality scanning equipment or by data transfer from a digital source (e.g., digital camera). Image resolution should be at least 400 ppi for color or grayscale images and 600 ppi (preferably higher) for black and white line drawings or graphs. Image size at these resolutions should be no less than 3 inches wide for vertical images and 5 inches wide for horizontally oriented figures. Do not use low-resolution digital formats (e.g., PowerPoint slides or JPEG). Back to Top
  • Add arrows and symbols to digitally created images using functions supplied with the imaging program. Do not use color marks on images intended for black and white reproduction.
  • Save each digital image as a TIFF file; use a compression function (such as LZW) that does not degrade the resolution, selecting PC byte order.
  • Do not use the caption function for figure legends.
  • Do not import images into the text document but transmit each image file with the manuscript either by disk, e-mail, or upload.
  • Type legends for all illustrations on a separate page, explaining abbreviations and symbols used in the figure. Previously published figures must be accompanied by written permission from the publisher to reproduce.
  • Request color reproduction at the time the manuscript is submitted for consideration. Four-color illustrations are printed at a cost to the author of $375 (US) each, which must be paid in advance of publication but does include 100 free reprints. Back to Top

 
MANUSCRIPT SUBMISSION
Manuscript materials must be submitted electronically by e-mail or file upload at our website. Submission by mail is not allowed without prior approval of the Editorial Office.
  • Access our Upload Center. On the submission page, enter your name, e-mail address, and fax number, then browse through your computer to locate the file(s) to upload. Enter additional comments below, but not the required submission letter. A separate file for this information, in the form of a cover letter, should be uploaded with the manuscript file(s). If you have more than 5 files to transmit, send them in multiple upload sessions. Indicate in the comments that multiple uploads are being used.
  • Digitized images (see Figures and Legends) may be sent by either method, but to avoid corruption of large files, it is advisable to archive and compress them using WinZip (MAC users should not employ Stuff-It).
  • A receipt for uploaded files is returned automatically and confirmed by e-mail from the Editorial Office within 3 business days.
  • For e-mail transfer of files, open a message and attach the files, noting in the body of the message your contact information and the number of files appended. Do not attempt to transmit multiple large (>1Mb) files in a single message; send separate messages for multiple files. Back to Top

PUBLICATION AND REPRINTS
Several weeks before the scheduled publication of an article, the corresponding author will receive via e-mail the edited version of the manuscript for approval. Three weeks after the author returns the approved/corrected edited version, a PDF file of the page proofs will be sent by e-mail for approval. At this stage, only correction of typographical errors or mistakes in the presentation of data can be made, provided the material is returned to the publisher within 72 hours.
    Reprints of articles will be furnished to authors when ordered in advance of publication and prepaid. An order form with price information will be sent to the author with the page proofs. Back to Top

CHECKLIST FOR MANUSCRIPT SUBMISSION
bullet Submission letter signed by all authors and containing the statements:
  1. There has been no duplicate publication or submission of any part of the work,
  2. All authors have read and approved the manuscript, and
  3. There is no financial arrangement or other relationship that could be construed as a conflict of interest.

Any financial support or conflict of interest must be disclosed in this letter and on the title page. Back to Top
bullet Original double-spaced manuscript consisting of
bullet Title page
bullet Abstract (formatted according to article type) and key words
bullet Text, subdivided into appropriate sections and typed double-spaced
bullet Acknowledgments
bullet References numbered consecutively and typed double-spaced
bullet Tables numbered consecutively
bullet Legends for all figures, typed double-spaced
bullet

Electronic files of text and images; include 1 set of printouts of all files with mail-in submission.
bullet

Request for color reproduction of specified images (if applicable)
bullet

Permission to reproduce previously published material Back to Top
copyright.gif